Amryt Pharma PLC News - AMYT

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

FeaturedFifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on April 18, 2023 REGISTRATION NO. 333-239763 REGISTRATION...

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on April 18, 2023 REGISTRATION NO. 333-239763 REGISTRATION...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc PR Newswire PARMA, Italy, DUBLIN and BOSTON, MA, April 12, 2023 ● ...

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc Acquisition positions Chiesi to expand...

2022 for Chiesi: The Group’s international growth continues

Turnover at €2 billion 749 million, with growth of 13.6% over 2021The European market remains at the center...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A ...

conix 2 years ago

Just when you think it is over....

👍️0

dhbuzz 3 years ago

https://ih.advfn.com/stock-market/NASDAQ/amryt-pharma-AMYT/stock-news/87570829/report-of-foreign-issuer-pursuant-to-rule-13a-16-o

👍️0

frans 4 years ago

shorts start at 11.69

👍️0

frans 4 years ago

shorts begin - valuation us 37.33

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amryt Pharma PLC (AMYT)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AMYT News

FeaturedFifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation

Post-effective Amendment to Registration Statement (pos Am)

Post-effective Amendment to Registration Statement (pos Am)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

2022 for Chiesi: The Group’s international growth continues

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

AMYT Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amryt Pharma PLC (AMYT) News

Amryt Pharma PLC (AMYT)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AMYT News

FeaturedFifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation

Post-effective Amendment to Registration Statement (pos Am)

Post-effective Amendment to Registration Statement (pos Am)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

2022 for Chiesi: The Group’s international growth continues

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

AMYT Discussion

Your Recent History

Go Ad-Free